Dark Forest Capital Management LP Buys New Stake in Maximus, Inc. (NYSE:MMS)

Dark Forest Capital Management LP purchased a new position in Maximus, Inc. (NYSE:MMS) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 7,439 shares of the health services provider’s stock, valued at approximately $555,000.

A number of other large investors have also made changes to their positions in the business. Vanguard Group Inc. grew its stake in Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock worth $488,829,000 after buying an additional 205,564 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider’s stock worth $105,001,000 after acquiring an additional 177,075 shares during the last quarter. Van Berkom & Associates Inc. increased its holdings in shares of Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock valued at $93,792,000 after acquiring an additional 98,264 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Maximus by 7.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider’s stock valued at $74,700,000 after purchasing an additional 71,598 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Maximus in the 4th quarter valued at approximately $71,443,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Trading Down 1.6 %

Shares of NYSE:MMS opened at $67.72 on Friday. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The stock has a market cap of $3.83 billion, a price-to-earnings ratio of 14.56 and a beta of 0.68. The business has a 50-day moving average price of $67.65 and a 200-day moving average price of $74.61.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.77%. Maximus’s payout ratio is currently 25.81%.

Insider Activity

In other news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company’s stock, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

MMS has been the topic of a number of recent analyst reports. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a report on Thursday, January 2nd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.